Xylazine Drives 900% Surge in Blood Infections

Article
par
Storey, Denis

Date de publication

2024

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Oui

Open Access / OK to Reproduce

Non

Évalué par des pairs

No

L’objectif

To discuss the implications of the prevalence of xylazine in the drug supply.

Constatations/points à retenir

Scripps Research developed a vaccine to counteract the effects of xylazine, offering potential relief for overdose symptoms. Research has linked the surge in group A staph infections to the introduction of xylazine in the street supply of drugs, highlighting injection drug use and homelessness as risk factors. The majority of patients with blood infections presented with severe skin wounds. 

Mots clés

About PWUD
Housing
Injecting drugs
Xylazine